Skip to content

Comparison of Stress Reduction Techniques

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02098018
Enrollment
100
Registered
2014-03-27
Start date
2015-04-30
Completion date
2016-08-31
Last updated
2016-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress

Brief summary

There are many ways to reduce stress. This study will compare 2 different programs for reducing stress. In addition to looking at how well the programs reduce stress, we will also ask questions about how these programs may be working.

Interventions

BEHAVIORALProgram 2

A well-established behavioral method for reducing stress. To maintain blinding, details will be given to participants after randomization.

BEHAVIORALProgram 1

A well-established behavioral method for reducing stress. To maintain blinding, details will be given to participants after randomization.

Sponsors

University of Connecticut
CollaboratorOTHER
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* 25-50 years of age * Able to engage in moderate physical activity * Interested in being treated for stress

Exclusion criteria

* Use of psychotropic medications within 6 months prior to study. * History of extreme physical or psychological trauma. * Medical conditions that would interfere with study procedures or confound results, such as diabetes, pregnancy, or paralysis. * Axis I psychiatric diagnosis; e.g., history of substance use disorder, psychotic disorder, bipolar disorder, or eating disorder.

Design outcomes

Primary

MeasureTime frameDescription
Change in Perceived Stressbaseline to 24 weeksParticipants will complete a short questionnaire about how stressed they feel. There will be 4 time points: baseline, week 8, week 12, week 24.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026